Small Molecule Services
Pharmaron provides a completely integrated platform for small-molecule drug discovery, preclinical and clinical development, and commercialization. Our comprehensive technology platforms offer support throughout the entire drug development and commercial lifecycle. Our industry knowledge, strong execution tactics, and end-to-end solutions shorten the drug discovery and development process.
In addition to classical small molecules, our expertise covers oligonucleotides, peptides, targeted protein degraders, antibody-drug conjugates, biologics, and cell and gene therapy products.
Small Molecule Services | Discovery | Preclinical | Clinical | Commercial |
---|---|---|---|---|
Discovery
|
Preclinical
|
Clinical
|
Commercial
|
|
Discovery
|
Preclinical
|
Clinical
|
Commercial
|
|
Discovery
|
Preclinical
|
Clinical
|
Commercial
|
|
Discovery
|
Preclinical
|
Clinical
|
Commercial
|
|
Discovery
|
Preclinical
|
Clinical
|
Commercial
|
|
Discovery
|
Preclinical
|
Clinical
|
Commercial
|
|
Discovery
|
Preclinical
|
Clinical
|
Commercial
|
|
Discovery
|
Preclinical
|
Clinical
|
Commercial
|
|
Discovery
|
Preclinical
|
Clinical
|
Commercial
|
|
Discovery
|
Preclinical
|
Clinical
|
Commercial
|
|
Discovery
|
Preclinical
|
Clinical
|
Commercial
|
|
Discovery
|
Preclinical
|
Clinical
|
Commercial
|
Interested in learning more?
Request more information about our drug discovery, preclinical and clinical development services